Search

Codexis Inc

Geschlossen

BrancheGesundheitswesen

1.32 -2.94

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.32

Max

1.3900000000000001

Schlüsselkennzahlen

By Trading Economics

Einkommen

-3.3M

-12M

Verkäufe

-333K

15M

EPS

-0.13

Gewinnspanne

-80.489

Angestellte

146

EBITDA

-4.3M

-11M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+374.45% upside

Dividenden

By Acuity

Nächstes Ergebnis

5. Nov. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-10M

151M

Vorheriger Eröffnungskurs

4.26

Vorheriger Schlusskurs

1.32

Nachrichtenstimmung

By Acuity

45%

55%

104 / 339 Ranking in Healthcare

Codexis Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

24. Sept. 2026, 20:07 UTC

Codexis Inc shares fell sharply, continuing a decline since Wednesday and closing below its 20-day moving average near the lower end of its one-month range.

23. Sept. 2026, 20:07 UTC

Codexis Inc shares fell as concerns about inflation and rising bond yields weighed on investor sentiment, pulling back after an earlier session rebound.

22. Sept. 2026, 20:01 UTC

Codexis Inc shares are up significantly in the current session, marking the third consecutive day of gains, despite remaining below the 20-day moving average.

18. Sept. 2026, 20:02 UTC

Codexis Inc is trading sharply higher, rebounding from three consecutive days of lower closes, though it remains below its 20-day moving average.

17. Sept. 2026, 20:01 UTC

Codexis Inc shares fell sharply, continuing a trend of three consecutive sessions lower, with the current price significantly below its 20-day moving average.

16. Sept. 2026, 19:22 UTC

Codexis Inc shares fell sharply amid a broader market downturn, pressured by rising U.S. Treasury yields and inflation concerns following strong retail sales data.

15. Sept. 2026, 20:01 UTC

Codexis Inc shares are trading lower as the NY Empire State Manufacturing Index fell to 7.6 in September, raising concerns about economic contraction.

4. Sept. 2026, 19:51 UTC

Codexis Inc shares are higher during Friday's session amid market volatility, reflecting a notable early-session gain despite recent declines and no specific news.

3. Sept. 2026, 20:07 UTC

Codexis Inc shares are lower during Thursday's session, marking four consecutive days of declines amid broader market weakness and rising jobless claims.

1. Sept. 2026, 20:01 UTC

Codexis Inc shares are lower amid broader market concerns over rising oil prices and inflation, with no specific news identified to explain the decline.

31. Aug. 2026, 20:02 UTC

Codexis Inc is gaining during Monday's session, despite an earlier pullback. Broader market conditions reflect heightened expectations for potential interest rate hikes.

28. Aug. 2026, 19:51 UTC

Codexis Inc. shares are trading lower today, having peaked earlier in the session before declining significantly. No specific news has been identified.

27. Aug. 2026, 20:07 UTC

Codexis Inc. shares are trading roughly flat amid minimal market movement. The stock remains above its 20-day moving average and near its one-month range.

26. Aug. 2026, 19:56 UTC

Codexis Inc. shares are lower today, reflecting a broader downward trend amid persistent inflationary pressures impacting market sentiment.

24. Aug. 2026, 19:16 UTC

Codexis Inc. shares are trading higher during Monday's session, with market focus on upcoming macroeconomic developments, including a speech by Federal Reserve Chair Kevin Warsh.

21. Aug. 2026, 19:46 UTC

Correlated Moves

Codexis Inc shares are higher today, reflecting strong momentum. This aligns with a broader biotechnology trend, supported by gains in the ARK Genomic Revolution ETF.

20. Aug. 2026, 19:16 UTC

Codexis Inc. shares are roughly flat as no specific news emerged. Intraday fluctuations ranged from a high of 8.23% to a low of -1.27%.

19. Aug. 2026, 20:02 UTC

Correlated Moves
News

Codexis Inc shares are higher today, supported by positive momentum in the genomics sector and the performance of the ARK Genomic Revolution ETF.

18. Aug. 2026, 19:41 UTC

Codexis Inc shares are trading lower during Tuesday's session, continuing a decline since Monday's close amid broader market concerns over rising treasury yields and inflation.

17. Aug. 2026, 19:56 UTC

News

Codexis shares are higher as Piper Sandler maintains Overweight rating and lowers price target to $8.00 from $9.00. Positive investor sentiment persists.

14. Aug. 2026, 19:46 UTC

Codexis Inc shares are lower, reflecting broader market weakness amid an unexpected decline in U.S. retail sales for July.

13. Aug. 2026, 19:51 UTC

News

Codexis reported Q2 2026 revenue of $14.9 million and a net loss of $12.0 million. Shares are trading roughly flat during Thursday's session.

12. Aug. 2026, 20:01 UTC

News

Codexis reported a narrower net loss of $12 million and reaffirmed revenue guidance of $72 million to $76 million, contributing to gains during Wednesday's session.

11. Aug. 2026, 23:51 UTC

News

Codexis reported second-quarter revenues of $14.9 million, exceeding estimates. Shares are trading higher in after-market hours following the positive earnings report and guidance.

10. Aug. 2026, 19:21 UTC

News

Codexis Inc shares are higher following a positive earnings report, with a loss per share of -$0.10, better than analysts' expectations of -$0.11.

7. Aug. 2026, 19:36 UTC

Codexis Inc shares are lower, reflecting broader market trends amid uncertainty over monetary policy and a weaker-than-expected jobs report.

6. Aug. 2026, 19:56 UTC

Codexis Inc shares are higher during Thursday's session, continuing an upward trend. The stock remains below its 20-day moving average.

5. Aug. 2026, 20:06 UTC

Codexis Inc shares are higher today, reflecting positive market sentiment amid a broader uptick in equities. No specific news was identified for the movement.

4. Aug. 2026, 19:56 UTC

Codexis Inc. shares are trading roughly flat, with no specific news identified. The stock remains below its 20-day moving average and near its one-month range low.

3. Aug. 2026, 19:44 UTC

News

Codexis Inc has appointed David Butler, PhD, to its Strategic Advisory Board. Shares are advancing, though still below the 20-day moving average.

Peer-Vergleich

Kursveränderung

Codexis Inc Prognose

Kursziel

By TipRanks

374.45% Vorteil

12-Monats-Prognose

Durchschnitt 6.5 USD  374.45%

Hoch 11 USD

Tief 2 USD

Basierend auf 5 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Codexis Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

5 ratings

4

Buy

1

Halten

0

Sell

Stimmung

By Acuity

104 / 339 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.